Nakamura, Toru, Schwander, Stephan K, Donnelly, Robert et al. · Clinical and vaccine immunology : CVI · 2010 · DOI
Researchers studied immune signaling molecules called cytokines in people with ME/CFS and fibromyalgia while they slept in a lab, comparing them to healthy people. Instead of finding signs of excessive inflammation (which some theories predicted), they found slightly elevated levels of a calming immune molecule called interleukin-10. These small changes might help explain why many ME/CFS patients struggle with disrupted sleep.
This study challenges the common assumption that ME/CFS is driven by excessive inflammation, suggesting instead a dysregulation pattern characterized by increased anti-inflammatory signaling. Understanding these immune abnormalities during sleep is particularly relevant since sleep disturbance is a cardinal symptom affecting quality of life in ME/CFS patients.
This study does not prove that elevated interleukin-10 causes ME/CFS or sleep problems—only that an association exists. The small magnitude of observed changes raises questions about clinical significance. Additionally, cross-sectional overnight measurement does not establish whether this cytokine pattern is a primary cause, secondary consequence of illness, or adaptive response to infection.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.